Gevorg Tamamyan

Gevorg Tamamyan is an Armenian pediatric oncologist and hematologist. He is Professor and Chairman of the Department of Pediatric Oncology and Hematology at Yerevan State Medical University and Chief Executive Officer of the Immune Oncology Research Institute (IMMONC) in Yerevan. He is co-founder and editor-in-chief of OncoDaily, an oncology media platform.[1][2][3][4]
Tamamyan has been involved in several international oncology societies, including the International Society of Pediatric Oncology (SIOP) and the Pediatric Oncology East and Mediterranean (POEM) Group,[5] a network of pediatric cancer centers across 28 countries. He has authored or co-authored peer-reviewed work published in journals including The Lancet, Lancet Oncology, Nature Reviews Cancer, and the Journal of Clinical Oncology.
Education and training
[edit]Tamamyan received his MD from Yerevan State Medical University in 2010, followed by an MSc in Advanced Oncology from the University of Ulm, Germany (2015), supported by a full two-year European School of Oncology scholarship. He completed his PhD in Oncology at YSMU in 2016 and was awarded the Doctor of Medical Sciences (DSc) degree, also from YSMU, in 2020.[6]
His postgraduate clinical training included a Postdoctoral Fellowship in the Department of Leukemia at the University of Texas MD Anderson Cancer Center (2014–2015), a fellowship at St. Anna Children's Hospital in Vienna (2013–2014), a Medical Research Fellowship with the European Organisation for Research and Treatment of Cancer (EORTC, 2014), and a pediatric hematology/oncology fellowship at China Medical University (2012). He also undertook a visiting scientist appointment at Dana-Farber / Boston Children's Cancer and Blood Disorders Center (2015).[7]
Executive and global health training includes programs at Harvard Medical School (High-Impact Cancer Research Program), the Harvard T.H. Chan School of Public Health (Global Health Delivery Intensive), and the University of Toronto (Global Health Diplomacy Executive Program). He received full scholarship support from the Harvard Medical School Center for Global Health Delivery – Dubai and the AGBU / Taktajian Family Fund. [8]
He obtained MD, Ph.D., and DSc degrees from the Yerevan State Medical University, an MSc degree in oncology from the University of Ulm, and completed a postdoc in leukemia at the University of Texas MD Anderson Cancer Center (USA) and a postgraduate program at the Harvard Medical School (USA).[1]
Career
[edit]He is the President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group, a cooperative group of 110 pediatric cancer centers from 28 countries, and chairman of the Board of the Institute of Cancer and Crisis.[9][10][11][12]
He was the chairman of the American Society of Clinical Oncology (ASCO) IDEA steering group, co-founder of the Institute of Cancer and Crisis, the Armenian Association of Hematology and Oncology, the 4090 Foundation, co-founder and a board member of the City of Smile Charitable Foundation.[13] He was the 2018-2019 President of the Harvard Club of Armenia.[1][14][15]
Academic and clinical roles
[edit]Since 2019, Tamamyan has served as Chairman and Professor of the Department of Pediatric Oncology and Hematology at YSMU, and as Adviser to the Rector for Science, Innovation, and Development since 2017. From 2019 to 2024 he was Head of the Pediatric Cancer and Blood Disorders Center of Armenia at Yeolyan Hematology and Oncology Center. He previously held positions as Associate Professor in the Department of Oncology at YSMU (2018–2019) and Adviser in Oncology to the Ministry of Health of Armenia (2018–2019).[16] He is a Preceptor at the School of Public Health, American University of Armenia.[17]
Pediatric oncology in Armenia
[edit]As Head of the Pediatric Cancer and Blood Disorders Center of Armenia, Tamamyan oversaw the introduction of standardized treatment protocols and development of multidisciplinary care. During this period, reported survival rates for pediatric malignancies at the center increased to approximately 80 percent.[18] He also initiated the first dedicated fellowship program in pediatric oncology and hematology in Armenia, established at Yerevan State Medical University.
Leukemia research
[edit]During his postdoctoral fellowship at MD Anderson Cancer Center, Tamamyan contributed to a study on malignancy-associated hemophagocytic lymphohistiocytosis (HLH) in adult patients, published in Cancer in 2016.[19]
International roles
[edit]Tamamyan serves as President of the International Society of Pediatric Oncology Asia Continental Branch (SIOP Asia) and President of the Pediatric Oncology East and Mediterranean (POEM) Group.[5]
In ASCO, he chaired the IDEA Working Group (2020–2021) and serves on the International Affairs Committee. At UICC, he served on the Emergency Solidarity Fund Advisory Board (2022–2023) and co-chaired a theme of the Abstract Committee for the World Cancer Congress 2024. [20]
Cancer in conflict
[edit]Tamamyan co-founded the Institute of Cancer and Crisis and was a co-author of a 2024 statement published in The Lancet, calling for improved cancer care for populations affected by armed conflict.[21] He also contributed a correspondence to Lancet Global Health (2021) on the impact of the Nagorno-Karabakh conflict on cancer patients.[22]
Selected publications
[edit]- Tamamyan, Gevorg N.; Kantarjian, Hagop M.; Ning, Jing (2016). "Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes". Cancer. 122 (18): 2857–2866. doi:10.1002/cncr.30084. PMID 27309146.
- Kazaryan, Airazat M.; Tamamyan, Gevorg N. (2021). "War in the time of COVID-19: humanitarian catastrophe in Nagorno-Karabakh and Armenia". Lancet Global Health. 9 (2): e133–e134. doi:10.1016/S2214-109X(20)30510-6. PMC 7833056. PMID 33253632.
- Bedirian, Karen; Tamamyan, Gevorg (2022). "Overview of cancer control in Armenia and policy implications". Frontiers in Oncology. 11 782581. doi:10.3389/fonc.2021.782581. PMC 8787108. PMID 35087754.[23]
- Sargsyan, Amalya; Tamamyan, Gevorg (2025). "Nationwide insights on immunotherapy in a low- and middle-income country: Armenia's struggle for equitable cancer care in an out-of-pocket system". JCO Global Oncology. 10: e2400001. doi:10.1200/GO.24.00001. PMC 11487994. PMID 39388655.
References
[edit]- 1 2 3 "immonc.org". immonc.org. Retrieved 2023-12-24.
- ↑ "ենտրոնի ղեկավար' Գևորգ Նաիրիի Թամամյան". blood.am. Retrieved 2023-12-24.
- ↑ "We Can Win, When We Are United: Dedicated to the Third Anniversary of the Pediatric Cancer and Blood Disorders Center of Armenia". ASCO Connection. 2022-03-10. Retrieved 2023-12-24.
- ↑ "Armenia to open three new cancer centers in 2023". armenpress.am. 12 April 2023. Retrieved 2023-12-24.
- 1 2 "Management Structure Pediatric Oncology East and Mediterranean (POEM) Group".
- ↑ "Cancer.am |Ամեն ինչ քաղցկեղի մասին". cancer.am. Retrieved 2026-05-13.
- ↑ "Arminfo". arminfo.info. Retrieved 2026-05-13.
- ↑ "AGBU | Armenian General Benevolent Union". agbu.org. Retrieved 2026-05-13.
- ↑ "Poem Group - About us - Management Structure". Poem Group. Retrieved 2023-12-24.
- ↑ "Poem Group - About us - Profile". Poem Group. Retrieved 2023-12-24.
- ↑ "Institute of Cancer and Crisis". Cancerandcrisis. Retrieved 2023-12-24.
- ↑ "Cancer Stories: The Art of Oncology: Cancer and Armed Conflict: Crossing Realities". aoopodcast.libsyn.com. Retrieved 2023-12-24.
- ↑ Goetz, Kristina. "'Our work is not in vain': City of Smile Foundation gives hope to children with cancer in Armenia". www.stjude.org. Retrieved 2023-12-30.
- ↑ "Cancer in My Community: Caring for Children With Cancer in Armenia". Cancer.Net. 2020-07-02. Retrieved 2023-12-24.
- ↑ "Founders". 4090 foundation. Retrieved 2023-12-24.
- ↑ "Ministry of Health Armenia Government Structure Official Statement" (PDF). April 2022.
- ↑ "Ինչով է զբաղվում Գևորգ Թամամյանը, ով աշխատանքից ազատվել է Սրբազան պայքարին աջակցելու համար | Armlur – Լուրեր Հայաստանից". Retrieved 2026-05-14.
- ↑ "We Can Win, When We Are United: Dedicated to the Third Anniversary of the Pediatric Cancer and Blood Disorders Center of Armenia". ASCO Connection. 2022-03-10.
- ↑ Tamamyan, Gevorg N.; Kantarjian, Hagop M.; Ning, Jing (2016). "Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes". Cancer. 122 (18): 2857–2866. doi:10.1002/cncr.30084. PMID 27309146.
- ↑ "We Can Win, When We Are United: Dedicated to the Third Anniversary of the Pediatric Cancer and Blood Disorders Center of Armenia". ASCO Connection. 2024. doi:10.1200/ACON.22.00042. Retrieved 2026-05-14.
- ↑ Ghebreyesus, Tedros Adhanom; Mired, Dina; Sullivan, Richard; Tamamyan, Gevorg (2024). "A manifesto on improving cancer care in conflict-impacted populations". The Lancet. 403 (10441): 2113–2118. doi:10.1016/S0140-6736(24)00372-3 (inactive 15 May 2026).
{{cite journal}}: CS1 maint: DOI inactive as of May 2026 (link) - ↑ Kazaryan, Airazat M.; Tamamyan, Gevorg N. (2021). "War in the time of COVID-19: humanitarian catastrophe in Nagorno-Karabakh and Armenia". The Lancet Global Health. 9 (2): e133–e134. doi:10.1016/S2214-109X(20)30510-6. PMC 7833056. PMID 33253632.
- ↑ Bedirian, Karen; Aghabekyan, Tigran; Mesrobian, Arianna; Shekherdimian, Shant; Zohrabyan, Davit; Safaryan, Liana; Sargsyan, Lilit; Avagyan, Armen; Harutyunyan, Lilit; Voskanyan, Astghik; Tadevosyan, Artashes; Melik-Nubaryan, Davit; Khachatryan, Parandzem; Saghatelyan, Tatul; Kostanyan, Mher (2022-01-11). "Overview of Cancer Control in Armenia and Policy Implications". Frontiers in Oncology. 11 782581. doi:10.3389/fonc.2021.782581. ISSN 2234-943X. PMC 8787108. PMID 35087754.